Fractyl Health Inc.
Clinical trials sponsored by Fractyl Health Inc., explained in plain language.
-
One-Time procedure aims to lock in weight loss after popular drugs
Disease control OngoingThis study is testing whether a one-time, outpatient endoscopic procedure can help people keep weight off after they stop taking a weight-loss medication (tirzepatide). Participants first take the medication to lose at least 15% of their body weight. They are then randomly assign…
Phase: NA • Sponsor: Fractyl Health Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
One-Time procedure aims to tame diabetes without daily drugs
Disease control TerminatedThis study is testing a one-time, minimally invasive procedure called Revita Duodenal Mucosal Resurfacing (DMR) to see if it can help control blood sugar in adults with type 2 diabetes. Participants, whose diabetes isn't well-controlled with at least one standard medication, are …
Phase: NA • Sponsor: Fractyl Health Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC